In Vitro Susceptibilities of Mycoplasma putrefaciens Field Isolates | Zendy

Nuno T. Antunes | Zendy; María M. Tavío | Zendy; Pascale Mercier | Zendy; Roger D. Ayling | Zendy; Waleed Momani | Zendy; P. Assunção | Zendy; Rubén S. Rosales | Zendy; José B. Poveda | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

In Vitro Susceptibilities of Mycoplasma putrefaciens Field Isolates

Author(s) -

Nuno T. Antunes,

María M. Tavío,

Pascale Mercier,

Roger D. Ayling,

Waleed Momani,

P. Assunção,

Rubén S. Rosales,

José B. Poveda

Publication year - 2007

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.00420-07

Subject(s) - microbiology and biotechnology , in vitro , mycoplasma , biology , virology , genetics

MICs were determined for 15 antimicrobial agents against 37Mycoplasma putrefaciens isolates. The most effective antimicrobial drug classes were the fluoroquinolones, the tetracyclines, the lincosamide lincomycin, and the macrolides. The susceptibility profile of the isolates correlated with the geographic origin. This is the first report of decreased susceptibility to the macrolides, lincomycin, and the tetracyclines inM. putrefaciens strains.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research